Lung Cancer Panel 1 EGFR ALK1
Introduction to the Lung Cancer Panel 1 EGFR ALK1 Test
The Lung Cancer Panel 1 EGFR ALK1 test is a specialized diagnostic tool designed to identify genetic mutations associated with lung cancer. This test is pivotal in the field of oncology, as it helps in determining the most effective treatment strategies for patients diagnosed with lung cancer.
What the Test Measures
This test specifically detects mutations in the EGFR (Epidermal Growth Factor Receptor) and ALK1 (Anaplastic Lymphoma Kinase) genes. These mutations can significantly influence the behavior of lung cancer and the response to targeted therapies.
Who Should Consider This Test?
Patients who exhibit symptoms of lung cancer such as persistent cough, chest pain, unexplained weight loss, or those with a history of smoking should consider this test. Additionally, individuals with risk factors like family history or exposure to carcinogens may benefit from early screening.
Benefits of Taking the Test
- Early detection of lung cancer can lead to timely intervention.
- Identifying genetic mutations can help tailor treatment plans, improving outcomes.
- Provides valuable information for oncologists to make informed decisions.
Understanding Your Results
Results from the Lung Cancer Panel 1 EGFR ALK1 test typically take 5-7 days. A positive result may indicate the presence of specific mutations, guiding treatment options. It’s essential to discuss your results with a healthcare professional for appropriate action.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Lung Cancer Panel 1 EGFR ALK1 | 360000 NGN | 480000 NGN |
Book Your Test Today!
To take the Lung Cancer Panel 1 EGFR ALK1 test, a doctor’s prescription is required, except for surgery and pregnancy cases or those planning to travel abroad. Don’t wait for symptoms to worsen; contact us today to schedule your test. Call or WhatsApp us at +2348077798758.
